The effect of pump speed and a vessel dilating medication on the exercise capacity of patients with left ventricular assist devices (artificial heart pumps)
Phase 1
Recruiting
- Conditions
- heart failureCardiovascular - Other cardiovascular diseases
- Registration Number
- ACTRN12622001376730
- Lead Sponsor
- St Vincent's Hospital Sydney
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
•Willingness to give written informed consent and willingness to participate to and comply with the study.
•Age more or equal to 18 or legal guardian has signed consent
•Clinically stable
•Ambulatory
•More than 2 months after pump insertion
Exclusion Criteria
•Active infection
•Exercise induced myocardial ischaemia or significant arrhythmias
•Recent acute coronary syndrome (<6 weeks)
•Inability to achieve a significant increase in LVAD flow without risk of suction
•Estimated peak exercise load less than 30 watts
•Regular use of sildenafil
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method